CVR number 31057019
Industry 86.2100 General medical practice activities

ALMENT PRAKTISERENDE LÆGER KJERULFF ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  4.7% 3.6% 3.5% 4.2% 2.4%  
Credit score (0-100)  47 52 51 48 63  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  0 0 0 0 0  
Gross profit  3,663 4,192 4,298 3,960 4,344  
EBITDA  188 490 403 371 700  
EBIT  -3.3 296 209 177 517  
Pre-tax profit (PTP)  -42.2 266.4 187.0 151.5 503.6  
Net earnings  -42.2 199.9 145.8 117.6 392.5  
Pre-tax profit without non-rec. items  -42.2 266 187 151 504  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Tangible assets total  116 95.5 61.1 26.7 2.9  
Shareholders equity total  398 218 274 277 552  
Interest-bearing liabilities  1,218 866 604 335 63.8  
Balance sheet total (assets)  1,850 1,892 1,518 989 1,302  
Net Debt  1,187 388 349 299 -466  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  0 0 0 0 0  
Net sales growth  -100.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,663 4,192 4,298 3,960 4,344  
Gross profit growth  23.4% 14.5% 2.5% -7.9% 9.7%  
Employees  4 4 4 4 3  
Employee growth %  0.0% 0.0% 0.0% 0.0% -25.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,850 1,892 1,518 989 1,302  
Balance sheet change%  -30.6% 2.3% -19.7% -34.9% 31.7%  
Added value  188.1 490.4 403.3 371.1 700.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -383 -374 -389 -389 -367  
Net sales trend  -1.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -0.1% 7.1% 4.9% 4.5% 11.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -0.1% 15.8% 12.3% 14.1% 45.1%  
ROI %  -0.2% 21.4% 19.9% 21.4% 73.1%  
ROE %  -5.5% 64.8% 59.2% 42.7% 94.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  21.5% 11.5% 18.0% 28.0% 42.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  631.0% 79.1% 86.6% 80.6% -66.6%  
Gearing %  305.7% 396.8% 220.4% 120.7% 11.6%  
Net interest  0 0 0 0 0  
Financing costs %  3.1% 2.9% 3.0% 5.4% 6.6%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.9 0.9 0.7 0.4 1.1  
Current Ratio  0.9 0.9 0.7 0.4 1.1  
Cash and cash equivalent  30.7 477.8 254.8 35.4 530.3  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -69.3 -130.5 -239.7 -310.8 95.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  47 123 101 93 233  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  47 123 101 93 233  
EBIT / employee  -1 74 52 44 172  
Net earnings / employee  -11 50 36 29 131